From her office in San Francisco's financial district, she hopes to wipe out diseases that plague developing nations but are ignored by Western drug companies for lack of profit possibilities.
Hale's prescription is to gain marketing rights to promising drug candidates that are owned by drug companies but sit undeveloped in labs.
The drug industry spent $32 billion on research and development in 2002, which yielded millions of possible drug compounds, many of which could fight diseases endemic to the developing world.
Source: http://www.tallahassee.com/mld/tallahassee/7907270.htm
[Editor: The preceding article was not written by A4M/WHN]
